Hopkins PMA - Search Results

1

The interstitial lung disease multidisciplinary meeting: A position statement from the Thoracic Society of Australia and New Zealand and the Lung Foundation Australia.

Prasad JD, Mahar A, Bleasel J, Ellis SJ, Chambers DC, Lake F, Hopkins PMA, Corte TJ, Allan H, Glaspole IN. Prasad JD, et al. Among authors: hopkins pma. Respirology. 2017 Oct;22(7):1459-1472. doi: 10.1111/resp.13163. Epub 2017 Sep 10. Respirology. 2017. PMID: 28891101 Free article.

2

Reversible posterior leukoencephalopathy syndrome: diagnosis and management in the setting of lung transplantation.

Tsang BK, Kermeen FD, Hopkins PM, Chambers DC. Tsang BK, et al. Intern Med J. 2010 Oct;40(10):716-20. doi: 10.1111/j.1445-5994.2010.02314.x. Intern Med J. 2010. PMID: 21038537

3

A novel approach to the assessment of lymphocytic bronchiolitis after lung transplantation--transbronchial brush.

Chambers DC, Hodge S, Hodge G, Yerkovich ST, Kermeen FD, Reynolds P, Holmes M, Hopkins PM. Chambers DC, et al. J Heart Lung Transplant. 2011 May;30(5):544-51. doi: 10.1016/j.healun.2010.10.018. Epub 2010 Dec 30. J Heart Lung Transplant. 2011. PMID: 21194972

4

The impact of pandemic influenza A H1N1 2009 on Australian lung transplant recipients.

Ng BJ, Glanville AR, Snell G, Musk M, Holmes M, Chambers DC, Hopkins PM. Ng BJ, et al. Am J Transplant. 2011 Mar;11(3):568-74. doi: 10.1111/j.1600-6143.2010.03422.x. Epub 2011 Feb 7. Am J Transplant. 2011. PMID: 21299829 Free article.

5

Survival after bronchiolitis obliterans syndrome.

Yerkovich ST, Hopkins PM, Chambers DC. Yerkovich ST, et al. Am J Respir Crit Care Med. 2011 Feb 15;183(4):554; author reply 554-5. doi: 10.1164/ajrccm.183.4.554a. Am J Respir Crit Care Med. 2011. PMID: 21325085 No abstract available.

6

The airway epithelium is a direct source of matrix degrading enzymes in bronchiolitis obliterans syndrome.

Banerjee B, Ling KM, Sutanto EN, Musk M, Yerkovich ST, Hopkins PM, Stick SM, Kicic A, Chambers DC. Banerjee B, et al. J Heart Lung Transplant. 2011 Oct;30(10):1175-85. doi: 10.1016/j.healun.2011.06.007. Epub 2011 Jul 23. J Heart Lung Transplant. 2011. PMID: 21784664

7

Idiopathic pulmonary fibrosis: is all-cause mortality a practical and realistic end-point for clinical trials?

Corte TJ, Goh NS, Glaspole IN, Zappala CJ, Hopkins PM, Wilsher ML. Corte TJ, et al. Thorax. 2013 May;68(5):491-2. doi: 10.1136/thoraxjnl-2012-203114. Epub 2013 Jan 23. Thorax. 2013. PMID: 23345573 No abstract available.

8

Impaired exercise capacity after lung transplantation is related to delayed recovery of muscle strength.

Walsh JR, Chambers DC, Davis RJ, Morris NR, Seale HE, Yerkovich ST, Hopkins PM. Walsh JR, et al. Clin Transplant. 2013 Jul-Aug;27(4):E504-11. doi: 10.1111/ctr.12163. Epub 2013 Jul 2. Clin Transplant. 2013. PMID: 23815281

9

Idiopathic pulmonary fibrosis: a degenerative disease requiring a regenerative approach.

Chambers DC, Hopkins PM. Chambers DC, et al. Am J Respir Crit Care Med. 2013 Jul 15;188(2):252-3. doi: 10.1164/rccm.201301-0192LE. Am J Respir Crit Care Med. 2013. PMID: 23855696 No abstract available.

10

A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis.

King TE Jr, Bradford WZ, Castro-Bernardini S, Fagan EA, Glaspole I, Glassberg MK, Gorina E, Hopkins PM, Kardatzke D, Lancaster L, Lederer DJ, Nathan SD, Pereira CA, Sahn SA, Sussman R, Swigris JJ, Noble PW; ASCEND Study Group. King TE Jr, et al. N Engl J Med. 2014 May 29;370(22):2083-92. doi: 10.1056/NEJMoa1402582. Epub 2014 May 18. N Engl J Med. 2014. PMID: 24836312 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

49 results

Search Page

Filters